<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04154540</url>
  </required_header>
  <id_info>
    <org_study_id>2017_17</org_study_id>
    <secondary_id>2017-A02861-52</secondary_id>
    <nct_id>NCT04154540</nct_id>
  </id_info>
  <brief_title>Posturography-Neuropathy</brief_title>
  <acronym>PONE</acronym>
  <official_title>Study of Gait and Posture in Subacute Acquired Neuropathies and in Hereditary Neuropathies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      If the classification between hereditary and acquired neuropathy is often easy, there is no
      completely specific marker allowing the distinction between the two etiologies. Clinical
      experience suggests that hereditary neuropathies have less impact on balance and gait than
      the acquired neuropathies at equivalent level of impairment, but this has never been clearly
      demonstrated.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Posturography (Romberg's quotient)</measure>
    <time_frame>Time 0 ; single session</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Timed Up and Go test (TUG)</measure>
    <time_frame>Time 0 ; single session</time_frame>
    <description>It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
the scores of ten seconds or less indicate normal mobility, 11-20 seconds are within normal limits for frail elderly and disabled patients, and greater than 20 seconds means the person needs assistance outside and indicates further examination and intervention. A score of 30 seconds or more suggests that the person may be prone to falls</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stride length (in millimeters) parameters</measure>
    <time_frame>Time 0 ; single session</time_frame>
    <description>Kinematic and Kinetic parameters of the gait initiation and the stabilised gait using the optoelectronic system (VICON®)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stride time (in seconde) parameters</measure>
    <time_frame>Time 0 ; single session</time_frame>
    <description>Kinematic and Kinetic parameters of the gait initiation and the stabilised gait using the optoelectronic system (VICON®)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>velocity (meter/seconde) parameters</measure>
    <time_frame>Time 0 ; single session</time_frame>
    <description>Kinematic and Kinetic parameters of the gait initiation and the stabilised gait using the optoelectronic system (VICON®)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cadence (step/min) parameters</measure>
    <time_frame>Time 0 ; single session</time_frame>
    <description>Kinematic and Kinetic parameters of the gait initiation and the stabilised gait using the optoelectronic system (VICON®)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Neuropathy Demyelinating</condition>
  <arm_group>
    <arm_group_label>demyelinating hereditary neuropathy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>adult patients with demyelinating hereditary neuropathy type CMT 1A.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>demyelinating inflammatory neuropathy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>adult patients with acquired demyelinating inflammatory neuropathy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Motion analysis</intervention_name>
    <description>Gait and posture recording</description>
    <arm_group_label>demyelinating hereditary neuropathy</arm_group_label>
    <arm_group_label>demyelinating inflammatory neuropathy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CMT1A for molecular-proven Group 1 (PMP22 duplication)

          -  IPDC likely or defined for Group 2

          -  Able to walk 10 m unassisted

        Exclusion Criteria:

          -  Neurological history other than neuropathy: epilepsy, stroke, dementia

          -  Pregnant women

          -  Person under guardianship or trusteeship

          -  Musculoskeletal conditions other than neuropathy impairing walking abilities

          -  Major comorbidity considered a contraindication by the investigator (cancer, unstable
             angor, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Céline TARD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Céline TARD, MD</last_name>
    <phone>0320445765</phone>
    <phone_ext>+33</phone_ext>
    <email>celine.tard@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Roger Salengro, CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Céline TARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>August 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2019</study_first_posted>
  <last_update_submitted>November 5, 2019</last_update_submitted>
  <last_update_submitted_qc>November 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gait</keyword>
  <keyword>Balance</keyword>
  <keyword>Posture</keyword>
  <keyword>Charcot-Marie-Tooth</keyword>
  <keyword>Chronic inflammatory demyelinating polyneuropathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

